These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 2933878)
41. [Clinical manifestation and patho-typing of biliary cast syndrome in patients after orthotopic liver transplantation]. Zhu XD; Shen ZY; Chen XG; Zang YJ Zhonghua Wai Ke Za Zhi; 2008 May; 46(10):728-32. PubMed ID: 18953924 [TBL] [Abstract][Full Text] [Related]
42. Primary biliary cirrhosis in Lithuania: diagnosis and clinical picture. Speiciene D; Irnius A; Leuschner U; Liakina V; Semuchiniene T; Barakauskiene A Med Sci Monit; 2007 Jul; 13(7):CR299-306. PubMed ID: 17599023 [TBL] [Abstract][Full Text] [Related]
43. Extracorporeal albumin dialysis: a procedure for prolonged relief of intractable pruritus in patients with primary biliary cirrhosis. Parés A; Cisneros L; Salmerón JM; Caballería L; Mas A; Torras A; Rodés J Am J Gastroenterol; 2004 Jun; 99(6):1105-10. PubMed ID: 15180733 [TBL] [Abstract][Full Text] [Related]
44. Clinical and pathological characteristics of the autoimmune hepatitis and primary biliary cirrhosis overlap syndrome. Suzuki Y; Arase Y; Ikeda K; Saitoh S; Tsubota A; Suzuki F; Kobayashi M; Akuta N; Someya T; Miyakawa Y; Kumada H J Gastroenterol Hepatol; 2004 Jun; 19(6):699-706. PubMed ID: 15151627 [TBL] [Abstract][Full Text] [Related]
45. Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis? Kilmurry MR; Heathcote EJ; Cauch-Dudek K; O'Rourke K; Bailey RJ; Blendis LM; Ghent CN; Minuk GY; Pappas SC; Scully LJ; Steinbrecher UP; Sutherland LR; Williams CN; Worobetz LJ Hepatology; 1996 May; 23(5):1148-53. PubMed ID: 8621147 [TBL] [Abstract][Full Text] [Related]
46. [-Therapy with ursodeoxycholic acid in primary biliary cirrhosis in pregnancy-]. Rudi J; Schönig T; Stremmel W Z Gastroenterol; 1996 Mar; 34(3):188-91. PubMed ID: 8650973 [TBL] [Abstract][Full Text] [Related]
47. Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid. Angulo P; Jorgensen RA; Keach JC; Dickson ER; Smith C; Lindor KD Hepatology; 2000 Feb; 31(2):318-23. PubMed ID: 10655252 [TBL] [Abstract][Full Text] [Related]
48. Experimental use of pravastatin in patients with primary biliary cirrhosis associated with hypercholesterolemia. Kurihara T; Akimoto M; Abe K; Ishiguro H; Niimi A; Maeda A; Shigemoto M; Yamashita K; Yokoyama I; Suzuki Y Clin Ther; 1993; 15(5):890-8. PubMed ID: 8269456 [TBL] [Abstract][Full Text] [Related]
49. Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients. ter Borg PC; Schalm SW; Hansen BE; van Buuren HR; Am J Gastroenterol; 2006 Sep; 101(9):2044-50. PubMed ID: 16848809 [TBL] [Abstract][Full Text] [Related]
50. Natural history and prognostic factors of primary biliary cirrhosis in Taiwan: a follow-up study up to 18 years. Su CW; Hung HH; Huo TI; Huang YH; Li CP; Lin HC; Lee PC; Lee SD; Wu JC Liver Int; 2008 Nov; 28(9):1305-13. PubMed ID: 18346129 [TBL] [Abstract][Full Text] [Related]
51. [Primary biliary cirrhosis]. Rosen R; Theodor E Harefuah; 1982 Dec; 103(11):298-300. PubMed ID: 7182336 [No Abstract] [Full Text] [Related]
52. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation. Kim WR; Poterucha JJ; Jorgensen RA; Batts KP; Homburger HA; Dickson ER; Krom RA; Wiesner RH; Lindor KD Hepatology; 1997 Jul; 26(1):22-6. PubMed ID: 9214447 [TBL] [Abstract][Full Text] [Related]